Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMO | Q99835 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ATF4 | P18848 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 5/20 | 0.38 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10292614 | 0.93 | SMO (0.41) | SMOCNR1CNR2EPHX2 | |
| SCHEMBL12017134 | 0.91 | SMO (0.42) | SMOCNR1EPHX2 | |
| SCHEMBL10003802 | 0.90 | SMO (0.51) | SMOKDM4EHPGDHSD17B10ATF4 | |
| SCHEMBL10003233 | 0.84 | SMO (0.52) | SMOHPGDEPHX2 | |
| SCHEMBL10293260 | 0.84 | SMO (0.52) | SMOENPP2EPHX2 | |
| SCHEMBL10004388 | 0.84 | SMO (0.52) | SMOCNR1EPHX2 | |
| SCHEMBL10003287 | 0.84 | SMO (0.52) | SMOEPHX2 | |
| SCHEMBL10003710 | 0.84 | SMO (0.52) | SMOHSD17B10CNR1CNR2EPHX2 | |
| SCHEMBL10004015 | 0.83 | SMO (0.57) | SMOKDM4EHPGDENPP2EPHX2 | |
| SCHEMBL10003168 | 0.82 | SMO (0.51) | SMOKDM4EHPGDEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2471789-A1 | FUSED HETEROCYCLIC RING DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2012-07-04 | — | — | EP | disclosed |